￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Targeted drug for EGFR mutated lung cancer: Pozitinib (Pozitinib)_ Kanghule

2025-10-19 11:44:20

Check Details
Analysis of the efficacy and adverse reactions of pozitinib in the treatment of lung cancer

2025-10-19 11:44:20

Check Details
How much does a box of targeted drug crizotinib cost after it is included in medical insurance?

2025-10-19 11:44:20

Check Details
How much does a box of the lung cancer targeted drug Bozitinib cost? Where can I buy it?

2025-10-19 11:44:20

Check Details
Study of Crizotinib (Xalkori) in Patients with Brain Metastases

2025-10-19 11:44:20

Check Details
The cost for a patient to treat lung cancer with pozitinib for one month

2025-10-19 11:44:20

Check Details
Ceritinib is effective in first-line treatment of crizotinib-resistant lung cancer patients

2025-10-19 11:44:20

Check Details
Ceritinib can be used to treat patients with non-small cell lung cancer who have progressed or are intolerant to crizotinib_ Kanghule

2025-10-19 11:44:20

Check Details
Efficacy of Xalkori (crizotinib) in patients with ROS1-rearranged non-small cell lung cancer

2025-10-19 11:44:20

Check Details
Treatment of Xalkore (crizotinib) in patients with advanced ALK-positive non-small cell lung cancer

2025-10-19 11:44:20

Check Details
Crizotinib (Xalkori) is suitable for ALK-positive non-small cell lung cancer

2025-10-19 11:44:20

Check Details
Entrectinib has long-term clinical efficacy in ROS1-positive non-small cell lung cancer

2025-10-19 11:44:20

Check Details
Category
相关知识